PolyPeptide Group

Peptide manufacturing comes with a critical challenge: protein aggregation during purification. At HubXchange Oligonucleotide & Peptides Xchange Europe 2025 in Munich, Germany, our Global Director and Head of Sales, Trishul Shah, will lead an expert roundtable: Tackling Protein Aggregates: Optimising Peptide Purification Processes 📅 December 2, 11:20–12:20 Join the discussion on: ✅ Why aggregates form during purification ✅ How solvent, pH, and temperature impact aggregation ✅ Strategies and technologies to minimize aggregation at scale 👉 Learn more: https://lnkd.in/dt4Uz5Uz #PeptideManufacturing #hubXchange #ProteinAggregates #RoundtableDiscussion

Connect with our team experts Sara Braeckevelt, PhD and Loïc Cornelissen at BioFIT Event, uniting public research institutions, academic spin-offs, and innovative biotech companies with industry leaders in pharma, biotech, and diagnostics!   📅2-3 December, 2025 📍 Strasbourg, France 🧬BioValley France, stand F39 Thank you BioValley France for the opportunity to join this influential event.   #BioFIT #LifeSciences #Peptides #BioValleyFrance

From tacos to trophies, our first annual Turkey Bowl was a celebration of teamwork and holiday spirit!✨ This November, our San Diego and Torrance teams kicked off the season with creativity and camaraderie: San Diego hosted a Turkey Bowl & Family Day at a local park, complete with disc golf, trivia, tacos, and a bouncy house for the kids. Torrance turned a rainy day into an indoor carnival, featuring inflatable games and friendly competition for the coveted Turkey Trophy 🏆. These moments remind us that connection and collaboration are at the heart of everything we do—whether on the field or in the office. Here’s to building traditions that spark connection and celebrate what makes our teams unique.💎 #Teamwork #Culture #HolidaySpirit #TurkeyBowl #LifeAtPolyPeptide #Thanksgiving

This week, PolyPeptide was pleased to be at the Jefferies Healthcare Conference in London—Europe's largest healthcare-dedicated investor gathering. Our CEO, Juan Jose Gonzalez, shared how we’re pushing boundaries in peptide therapeutics—driven by global reach, innovation, and a bold growth strategy. From a rapidly expanding market to our commitment to sustainability and operational excellence, PolyPeptide is shaping the future of peptide manufacturing. Thank you to everyone who joined us and to Jefferies for bringing together such a dynamic community! #JefferiesHealthcare #PolyPeptide #Innovation #Growth You can view the presentation here: https://lnkd.in/gJhsai28

🔔 Reminder: Don’t miss our upcoming webinar! Topic: Enhanced Peptide Manufacturing Using Backbone N-Protecting Groups. A deep dive into advanced solid-phase peptide synthesis (SPPS) strategies. 📅 Date: November 25, 2025 Key takeaways: ✅ How backbone protection strategies solve common manufacturing challenges ✅ Improve synthesis efficiency and product quality ✅ Practical approaches for complex peptide sequences Who should attend? Professionals in process development, QC, analytical sciences, formulation, regulatory affairs, or peptide research. Expert speakers: Linda Haugaard-Kedström, John Karas, and Sam Paravizzini will share real-world applications and best practices. 👉 Register now: https://lnkd.in/dUnkdAKv #PeptideManufacturing #PeptideSynthesis #Webinar

We’re thrilled to share that PolyPeptide will be at BTD-Bioteknikdagarna at Lund University on Thursday, November 20th, from 13:00–17:00, meeting Biotechnology students who are ready to take the next step in their careers. At PolyPeptide, our culture is built on growth, collaboration, and purpose. We believe in creating an environment where curiosity is encouraged, learning never stops, and every contribution helps improve the health of millions of patients worldwide. Joining us means being part of a team that: Values innovation and scientific excellence Connects individual careers to global health impact Offers opportunities to grow alongside a company on an exciting journey If you’re passionate about science and want to be part of a workplace where your work truly matters, we’d love to meet you. Let’s explore how your career can grow with us—and how together, we can make a difference. Visit our Career page: https://bit.ly/4pBbXvt   #PolyPeptideGroup #BiotechCareers #LundUniversity #LifeAtPolyPeptide #CareerGrowth #GlobalHealthImpact #Bioteknikdagarna #CultureOfGrowth #PurposeDrivenWork

Great insights at PSCC! On November 12, Paris Saclay Cancer Cluster (PSCC) brought together researchers, entrepreneurs, and industry leaders to discuss the future of therapeutic peptides, their development challenges, and new collaboration opportunities between biotechs, CDMOs, and investors. We’re proud that Fabien ROUSSET, Director Global Innovation, contributed to these rich exchanges, helping drive progress in oncology and peptide innovation. 👏 A big thank you to all speakers and participants for fostering such an inspiring dialogue! #Innovation #Peptides #Oncology #PSCC

📍Join PolyPeptide at TIDES Europe, Booth 214, at the Congress Center Basel, Switzerland, November 11–13, 2025 We’re proud to showcase our expertise in peptide therapeutics and invite you to attend our featured presentations: 🎤  Robert Hagopian, Director, Biotech Partnerships/Key Opinion Leader “Challenges of Raw Material Acquisition for Peptide Synthesis” 🗓️ November 11, 09:05 🎤 Francesco Terzani, Scientist Innovation “PolyPeptide’s Approach to Process Intensification: Tackling the Increasing Peptide Demand” 🗓️ November 12, 14:30 See more details 👉 https://lnkd.in/dbH6AjJn Or schedule a meeting with our team Loïc Cornelissen and Sara Braeckevelt, PhD to discuss your peptide projects. #TIDESEU2025 #PeptideTherapeutics #PolyPeptide #Innovation

💊 Back from CPHI Frankfurt Last week, our team was in Frankfurt for CPHI Worldwide—one of the industry's biggest gatherings, with nearly 2,500 exhibitors and over 60,000 attendees from around the world. 🌍 The highlight? The conversations. We talked market trends with customers, explored new projects with partners, debated the future of peptides with industry experts, and strengthened relationships with suppliers. Every discussion brought something valuable. To everyone who stopped by our booth—thank you. Your insights, challenges, and ideas are what push this industry forward. These face-to-face connections remind us why collaboration matters so much in what we do. We left Frankfurt energized and looking forward to what's next in the peptide space. ✨

Comprehensive Peptide Manufacturing Solution for the U.S. Market 🤝 We've entered into a collaboration agreement with Lifecore Biomedical, intended to provide an integrated, end-to-end peptide manufacturing solution for the U.S. pharmaceutical market. 🔗This collaboration will combine our capabilities in peptide development and manufacturing with Lifecore's expertise in formulation, fill/finish, and packaging—designed to create a seamless transition from drug substance to drug product. What this means: 🎯 Accelerated development timelines for peptide-based therapeutics 🎯 Reduced development costs and associated risks 🎯 A fully U.S.-based supply chain with enhanced regulatory alignment 🎯 Customers supported through laboratory transfers, equipment comparability, method transfer, and release testing As our partner Mark DaFonseca, Chief Commercial Officer at Lifecore, noted: "This collaboration brings together two leading organizations, each an expert in its field, to deliver value to peptide-based pharmaceutical developers." Our Chief Commercial Officer, Stéphane Varray adds: "By combining our expertise, we're uniquely positioned to accelerate customers' path to market—supporting everything from lab transfers to release testing with robust quality oversight throughout." This agreement comes at a time of increasing demand for peptide-based therapeutics, where integrated manufacturing solutions and supply chain reliability are becoming increasingly critical for pharmaceutical developers. #PeptideManufacturing #CDMO #Biopharmaceuticals #DrugDevelopment #SupplyChain #LifeSciences Read more: https://lnkd.in/gHxCs6qc